Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug launch
Pharma
Akebia sketches out pivotal Vafseo study in nondialysis patients
Akebia plans to kick off a phase 3 trial to assess Vafseo as a potential treatment for anemia in late-stage CKD patients who aren’t on dialysis.
Fraiser Kansteiner
Mar 13, 2025 3:28pm
Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis
Mar 12, 2025 2:13pm
Neurotech nabs first nod for eye disease cell therapy implant
Mar 10, 2025 9:50am
Amid ongoing launches, Novo eyes rare disease leadership
Mar 7, 2025 9:20am
Bavarian Nordic CEO highlights travel health as key sales driver
Mar 6, 2025 9:04am
Want HCPs’ attention? Here’s what messages resonate and when
Mar 4, 2025 11:40am
